학술논문
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
Document Type
article
Author
A. Negri; C. Ward; A. Bucci; G. D’Angelo; P. Cauchy; A. Radesco; A. B. Ventura; D. S. Walton; M. Clarke; B. Mandriani; S. A. Pappagallo; P. Mondelli; K. Liao; G. Gargano; G. M. Zaccaria; L. Viggiano; F. M. Lasorsa; A. Ahmed; D. Di Molfetta; G. Fiermonte; M. Cives; A. Guarini; M. C. Vegliante; S. Ciavarella; J. Frampton; G. Volpe
Source
Cell Death and Disease, Vol 14, Iss 11, Pp 1-11 (2023)
Subject
Language
English
ISSN
2041-4889
Abstract
Abstract The transcription factor MYB plays a pivotal role in haematopoietic homoeostasis and its aberrant expression is involved in the genesis and maintenance of acute myeloid leukaemia (AML). We have previously demonstrated that not all AML subtypes display the same dependency on MYB expression and that such variability is dictated by the nature of the driver mutation. However, whether this difference in MYB dependency is a general trend in AML remains to be further elucidated. Here, we investigate the role of MYB in human leukaemia by performing siRNA-mediated knock-down in cell line models of AML with different driver lesions. We show that the characteristic reduction in proliferation and the concomitant induction of myeloid differentiation that is observed in MLL-rearranged and t(8;21) leukaemias upon MYB suppression is not seen in AML cells with a complex karyotype. Transcriptome analyses revealed that MYB ablation produces consensual increase of MAFB expression in MYB-dependent cells and, interestingly, the ectopic expression of MAFB could phenocopy the effect of MYB suppression. Accordingly, in silico stratification analyses of molecular data from AML patients revealed a reciprocal relationship between MYB and MAFB expression, highlighting a novel biological interconnection between these two factors in AML and supporting new rationales of MAFB targeting in MLL-rearranged leukaemias.